Groundbreaking Immunotherapy for Brain Cancer to Enter Large-Scale Clinical Trial
2025-02-27
An Australian-led international clinical trial will scientifically investigate the efficacy of a double immunotherapy approach in treating glioblastoma. The trial, led by The Brain Cancer Centre, a collaboration of world-leading oncologists, immunologists, and neurosurgeons, will test double immunotherapy, with some patients also receiving chemotherapy. While early results are promising, researchers emphasize the need for a large-scale clinical trial before it can be considered a breakthrough.